Evidence map›Paper›PMID 34209083›Full record

ReviewJournal of clinical medicine2021

Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options?

Juan M Buades, Lourdes Craver, Maria Dolores Del Pino, Mario Prieto-Velasco, Juan C Ruiz, Mercedes Salgueira, Patricia de Sequera, Nicanor Vega

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. HFrontiers in chemistry · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Juan M BuadesDepartment of Nephrology, Hospital Universitario Son Llàtzer, Balearic Islands, 07198 Palma de Mallorca, Spain.ORCID 0000-0001-6383-6110
Lourdes CraverDepartment of Nephrology, Hospital Universitario Arnau de Vilanova, 25198 Lleida, Spain.
Maria Dolores Del PinoDepartment of Nephrology, Complejo Hospitalario Torrecárdenas de Almería, 04009 Almería, Spain.
Mario Prieto-VelascoDepartment of Nephrology, Complejo Asistencial Universitario de Leon, 24001 León, Spain.
Juan C RuizDepartment of Nephrology, Valdecilla Hospital, University of Cantabria, 39008 Santander, Spain.ORCID 0000-0002-7904-8730
Mercedes SalgueiraDepartment of Nephrology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Patricia de SequeraDepartment of Nephrology, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.
Nicanor VegaDepartment of Nephrology, Hospital Universitario de Gran Canaria Dr. Negrín, 35010 Las Palmas de Gran Canaria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is the most frequent cause of kidney failure (KF). There are large variations in the incidence rates of kidney replacement therapy (KRT). Late referral to nephrology services has been associated with an increased risk of adverse outcomes. In many countries, when patients reach severely reduced glomerular filtration rate (GFR), they are managed by multidisciplinary teams led by nephrologists. In these clinics, efforts will continue to halt chronic kidney disease (CKD) progression and to prevent cardiovascular mortality and morbidity. In patients with diabetes and severely reduced GFR and KF, treating hyperglycemia is a challenge, since some drugs are contraindicated and most of them require dose adjustments. Even more, a decision-making process will help in deciding whether the patient would prefer comprehensive conservative care or KRT. On many occasions, this decision will be conditioned by diabetes mellitus itself. Effective education should cover the necessary information for the patient and family to answer these questions: 1. Should I go for KRT or not? 2. If the answer is KRT, dialysis and/or transplantation? 3. Dialysis at home or in center? 4. If dialysis at home, peritoneal dialysis or home hemodialysis? 5. If transplantation is desired, discuss the options of whether the donation would be from a living or deceased donor. This review addresses the determinant factors with an impact on DKD, aiming to shed light on the specific needs that arise in the management and recommendations on how to achieve a comprehensive approach to the diabetic patient with chronic kidney disease.

Indexed as

chronic kidney diseasecomprehensive conservative carediabetic kidney diseasehemodialysishome hemodialysiskidney failurekidney replacement therapykidney transplantperitoneal dialysis

Identifiers

PMID34209083
PMCPMC8268456

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.